
Rick McKellar, BS
Advertisement
Articles by Rick McKellar, BS


Formularies of the future should use evidence-produced CER to better target, not limit, diabetes care.
Advertisement
Latest Updated Articles
Comparative Effectiveness Research and Formulary Placement: The Case of DiabetesPublished: February 12th 2013 | Updated:
Comparative Effectiveness Research and Formulary Placement: The Case of DiabetesPublished: July 2nd 2013 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
CD19 CAR T-Cell Therapy Shows Promising Activity in Richter Transformation
2
2025 Hypertension Guideline Updates Presented at AHA Scientific Sessions
3
Inside the VA’s Hub-and-Spoke Model for Multiple Sclerosis Care: Rebecca Spain, MD
4
New Evidence Strengthens Case for Modifiable Risk Factors in Multiple Sclerosis
5



